Gene	Alteration	Tumor	Stage	Action_Type	Action	Drug_Class	FDA_Approval_Status	Level_of_Evidence	Mutation_Class	Summary	PMID_IDs	Clinical_Trial_IDs	Abstract_Citations	Applicable_SubtypesABL1	Translocation	CML	NULL	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic					ABL1	Translocation	CML	NULL	Sensitivity	dasatinib		TRUE	Clinically_validated	Somatic					ABL1	Translocation	CML	NULL	Sensitivity	nilotinib		TRUE	Clinically_validated	Somatic					ABL1	p.T315I	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.Y253H	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.Y253F	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.E255K	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.E255V	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	Amplification	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.T670I	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.V654A	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.D816A	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.D820A	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.D816G	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.D816H	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.D816V	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.D820E	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.D820G	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ABL1	p.D820Y	CML	NULL	Resistance	imatinib		TRUE	NULL	Somatic					ALK	Translocation	Lung	NULL	Sensitivity	crizotinib		TRUE	NULL	Somatic					AR	Amplification	Prostate	NULL	Resistance	Androgen_deprivation		TRUE	NULL	Somatic					AR	Amplification	Prostate	NULL	Sensitivity	MDV3100		FALSE	NULL	Somatic					BCL2	Translocation	Lymphoma	NULL	Prognostic	NULL		NULL	NULL	Somatic					BCL2	Translocation	Lymphoma	NULL	Diagnostic	NULL		NULL	NULL	Somatic					BRAF	p.V600E	Melanoma	NULL	Sensitivity	Vemurafenib		TRUE	NULL	Somatic					BRAF	p.V600K	Melanoma	NULL	Sensitivity	Vemurafenib		TRUE	NULL	Somatic					BRAF	p.V600E	Colorectal	NULL	Resistance	NULL		NULL	NULL	Somatic					BRAF	p.V600E	Colorectal	NULL	Prognostic	NULL		NULL	NULL	Somatic					BRAF	Amplification	Melanoma	NULL	Resistance	NULL		TRUE	Preclinical	Somatic					CCND1	Amplification	Breast	NULL	Resistance	Hormone_therapy		TRUE	NULL	Somatic					CCND1	Amplification	Breast	NULL	Prognostic	NULL		NULL	NULL	Somatic					CCND1	Amplification	Breast	NULL	Diagnostic	NULL		NULL	NULL	Somatic					KIT	p.D52N	Myeloproliferative_disorders	NULL	Sensitivity	imatinib		TRUE	Limited	Somatic		9168438			Myelofibrosis|CMLKIT	p.D52N	Myeloproliferative_disorders	NULL	Sensitivity	sunitinib		TRUE	Limited	Somatic		9168438			Myelofibrosis|CMLKIT	p.F504insAY	GIST	Metastatic	Resistance	imatinib		TRUE	Clinically_validated	Somatic	Requires increased dose of TKI	16534250			KIT	p.C620del	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		12181401			KIT	p.D631G	Melanoma	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic	*There is c.1727T>C and c.1669T>A!	21642685|12181401			KIT	p.C634R	Melanoma	Metastatic	Sensitivity	sorafenib		TRUE	Limited	Somatic	*There is c.1727T>C and c.1669T>A!	20372153			KIT	p.C634Y	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic	Pediatric	18483389|12181401|16954519			KIT	p.C634W	Systemic_mastocytosis	NULL	Resistance	imatinib		TRUE	Limited	Somatic		17259998			KIT	p.A640>VRP	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		12181401			KIT	p.E768D	Melanoma	Metastatic	Sensitivity	imatinib		TRUE	NULL	Somatic		21642685|21690468			KIT	p.A883F	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		12181401|16954519			KIT	p.A883F	Melanoma	Metastatic	Sensitivity	imatinib		TRUE	NULL	Somatic		21642685|21690468			KIT	p.E901del	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		12181401|16954519			KIT	p.M918T	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic					KIT	p.T315I	Melanoma	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		21642685|18980976|21690468			KIT	p.Y253H	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		15545668			KIT	p.Y253F	Thymic_carcinoma	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		15201427			KIT	p.E255K	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		18483389|12181401|16954519			KIT	p.E255V	Systemic_mastocytosis	NULL	Sensitivity	bafetinib		FALSE	Preclinical	Somatic		20685234			KIT	p.T670I	Systemic_mastocytosis	NULL	Diagnostic	NULL		NULL	NULL	Somatic		18404201			KIT	p.V654A	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		12181401|16954519			KIT	p.V600E	Melanoma	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		21642685|21690468			KIT	p.V600K	GIST	Metastatic	Prognostic	NULL		NULL	NULL	Somatic		12721243			KIT	p.V600E	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		12181401|16954519			KIT	p.V600E	Melanoma	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		20372153|21642685|21690468			KIT	p.V600E	Melanoma	Metastatic	Sensitivity	sorafenib		TRUE	Limited	Somatic		20372153			KIT	p.V600E	GIST	Metastatic	Sensitivity	imatinib		TRUE	Clinically_validated	Somatic		12181401|16954519			KIT	p.D594G	Melanoma	Metastatic	Sensitivity	imatinib		TRUE	NULL	Somatic		21642685|21690468|18510589			KIT	p.P585P	NHL	NULL	Diagnostic	NULL		NULL	NULL	Somatic		11927008			Non-Hodgkin's Lymphoma of adrenal gland|NK/T-cell lymphomaKIT	p.V654A	GIST	Metastatic	Resistance	imatinib		TRUE	Limited	Somatic		16954519			KIT	p.T670I	GIST	Metastatic	Resistance	imatinib		TRUE	Limited	Somatic		18294292			KIT	p.T670I	GIST	Metastatic	Sensitivity	bortezomib		TRUE	Preclinical	Somatic		20028860			KIT	p.D816Y	AML	NULL	Sensitivity	SU11657		FALSE	Preclinical	Somatic		20435347|15339674			KIT	p.D816Y	AML	NULL	Sensitivity	imatinib		TRUE	Limited	Somatic		21403650			KIT	p.D816H	GIST	Metastatic	Resistance	imatinib		TRUE	Limited	Somatic		16954519			KIT	p.D816H	Melanoma	Metastatic	Prognostic	NULL		NULL	NULL	Somatic		16908931			KIT	p.D816V	GIST	Metastatic	Resistance	imatinib		TRUE	Clinically_validated	Somatic		20553795			KIT	p.D816V	Systemic_mastocytosis	NULL	Sensitivity	bafetinib		FALSE	Preclinical	Somatic		20685234			KIT	p.N822K	GIST	Metastatic	Resistance	imatinib		TRUE	Limited	Somatic		18294292|16954519			KIT	p.N822K	AML	NULL	Diagnostic	NULL		NULL	NULL	Somatic		18977345			KIT	p.V825A	AML	NULL	Prognostic	NULL		NULL	NULL	Somatic	Poor prognosis	16291595			KIT	p.Y823D	GIST	Metastatic	Resistance	imatinib		TRUE	Limited	Somatic		16954519|17875769|15930355			KIT	p.C809G	GIST	Metastatic	Resistance	imatinib		TRUE	Limited	Somatic		16954519|18294292			KIT	p.D820A	GIST	Metastatic	Resistance	imatinib		TRUE	Limited	Somatic		16954519			KIT	p.D820G	GIST	Metastatic	Resistance	imatinib		TRUE	Limited	Somatic		16954519|16551858			KIT	p.D820G	Testicular	Metastatic	Diagnostic	NULL		NULL	NULL	Germline		15150569			Germ cellKIT	p.D820G	AML	NULL	Prognostic	NULL		NULL	Limited	Somatic		19603346|19644024			KIT	p.D820G	Systemic_mastocytosis	NULL	Diagnostic	NULL		NULL	Limited	Somatic		9029028			KIT	Amplification	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		???			KIT	Amplification	Melanoma	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		21642685|21690468			KIT	p.E839K	Systemic_mastocytosis	NULL	Diagnostic	NULL		NULL	NULL	Somatic		9990072			KRAS	p.G12D	Lung	Metastatic	Diagnostic	NULL		NULL	Limited	Somatic	"EGFR mutant, no impact on overall survival"	17596643¾			Non-small cell lung cancer | EGFR mutantKRAS	p.G12D	Colorectal	Metastatic	Prognostic	NULL		NULL	Limited	Somatic	Poor prognosis	16900509			KRAS	p.G12D	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18946061			KRAS	p.G12V	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316791			KRAS	p.G12A	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316791			KRAS	p.G12C	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316791			KRAS	p.G12R	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316792			KRAS	p.G12S	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316793			KRAS	p.G13A	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316794			KRAS	p.G13D	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316795			KRAS	p.G13V	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316796			KRAS	p.G13S	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316797			KRAS	p.G13C	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316798			KRAS	p.G13R	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316799			KRAS	p.L19F	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316800			KRAS	p.L19F	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316801			KRAS	p.Q22K	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316802			KRAS	p.A59T	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316803			KRAS	p.Q61H	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316804			KRAS	p.Q61H	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316805			KRAS	p.Q61P	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316806			KRAS	p.Q61R	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316807			KRAS	p.Q61L	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316808			KRAS	p.Q61E	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316809			KRAS	p.Q61K	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316810			KRAS	p.A146T	Colorectal	Metastatic	Resistance	cetuximab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316811			KRAS	Wild_type	Colorectal	Metastatic	Sensitivity	cetuximab		TRUE	Clinically_validated	Somatic		18316791			KRAS	p.G12D	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18946061			KRAS	p.G12V	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316791			KRAS	p.G12A	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316791			KRAS	p.G12C	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316791			KRAS	p.G12R	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316792			KRAS	p.G12S	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316793			KRAS	p.G13A	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316794			KRAS	p.G13D	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316795			KRAS	p.G13V	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316796			KRAS	p.G13S	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316797			KRAS	p.G13C	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316798			KRAS	p.G13R	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316799			KRAS	p.L19F	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316800			KRAS	p.L19F	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316801			KRAS	p.Q22K	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316802			KRAS	p.A59T	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316803			KRAS	p.Q61H	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316804			KRAS	p.Q61H	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316805			KRAS	p.Q61P	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316806			KRAS	p.Q61R	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316807			KRAS	p.Q61L	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316808			KRAS	p.Q61E	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316809			KRAS	p.Q61K	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316810			KRAS	p.A146T	Colorectal	Metastatic	Resistance	panitumumab	EGFR monoclonal antibody	TRUE	Clinically_validated	Somatic		18316811			KRAS	Wild_type	Colorectal	Metastatic	Sensitivity	panitumumab		TRUE	Clinically_validated	Somatic		18316791			MAP2K1	p.Q56P	Lung	Metastatic	Resistance	erlotinib		TRUE	Limited	Somatic		18632602			NSCLCMAP2K1	p.K57N	Lung	Metastatic	Resistance	erlotinib		TRUE	Limited	Somatic		18632602			NSCLCMAP2K1	p.K57N	Lung	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Preclinical	Somatic		18632602	NCT00866177		MAP2K1	p.D67N	Lung	Metastatic	Resistance	erlotinib		TRUE	Limited	Somatic		18632602			NSCLCMAP2K1	p.C121S	Melanoma	Metastatic	Resistance	vemurafenib		TRUE	Limited	Somatic		21383288			MAP2K1	p.C121S	Melanoma	Metastatic	Resistance	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		21383288			MAP2K1	p.P124L	Melanoma	Metastatic	Resistance	vemurafenib		TRUE	Limited	Somatic		19915144			MAP2K1	p.P124L	Melanoma	Metastatic	Resistance	selumetinib		FALSE	Limited	Somatic		19915144			MAP2K1	p.Q56P	Lung	Metastatic	Resistance	gefitinib		TRUE	Limited	Somatic		18632602			NSCLCMAP2K1	p.K57N	Lung	Metastatic	Resistance	gefitinib		TRUE	Limited	Somatic		18632602			NSCLCMAP2K1	p.D67N	Lung	Metastatic	Resistance	gefitinib		TRUE	Limited	Somatic		18632602			NSCLCMDM2	Amplification	Gastric	Metastatic	Sensitivity	nutlin-3	MDM2 inhibitor	FALSE	Preclinical	Somatic		21205074			MET	Amplification	Renal_cell_carcinoma	Metastatic	Sensitivity	SU11274	MET inhibitor	FALSE	Preclinical	Somatic					MET	p.T1010I	Head_and_neck	Metastatic	Sensitivity	SU11274	MET inhibitor	FALSE	Preclinical	Somatic		19318576			MET	p.H1112Y	Papillary_renal_carcinoma	Metastatic	Diagnostic	NULL		NULL	NULL	Somatic		10327054			MET	p.H1112R	Renal_cell_carcinoma	Metastatic	Diagnostic	NULL		NULL	NULL	Germline		12460923			MET	p.Y1248H	Papillary_renal_carcinoma	Metastatic	Diagnostic	NULL		NULL	NULL	Somatic					MET	p.Y1248C	Papillary_renal_carcinoma	Metastatic	Diagnostic	NULL		NULL	NULL	Somatic					MET	p.Y1230C	Renal_cell_carcinoma	Metastatic	Diagnostic	NULL		NULL	NULL	Germline		10734314			MET	p.M1268T	Renal_cell_carcinoma	Metastatic	Diagnostic	NULL		NULL	NULL	Somatic					MLH1	p.V384D	Colorectal	Metastatic	Diagnostic	NULL		NULL	NULL	Somatic	Lynch Syndrome				MLL	Translocation	ALL	Metastatic	Prognostic	Transplant		TRUE	Clinically_validated	Somatic					MLL	Translocation	ALL	Metastatic	Sensitivity	EPZ004777	DOT1L inhibitor	FALSE	Preclinical	Somatic					MPL	p.W515L	Myeloproliferative_disorders	Metastatic	Sensitivity	EXEL-8232	JAK2 inihibtor	FALSE	Preclinical	Somatic		22005786			MTOR	Wild_type	Renal_cell_carcinoma	Metastatic	Sensitivity	temserolimus		TRUE	Clinically_validated	Somatic					MTOR	Wild_type	Breast	Metastatic	Sensitivity	temserolimus		TRUE	Clinically_validated	Somatic		Baselga NEJM 12/2011 (no PMID yet)			MTOR	Wild_type	Renal_cell_carcinoma	Metastatic	Sensitivity	everolimus		TRUE	Clinically_validated	Somatic					MTOR	Wild_type	Breast	Metastatic	Sensitivity	everolimus		TRUE	Clinically_validated	Somatic		Baselga NEJM 12/2011 (no PMID yet)			MYC	Amplification	Medulloblastoma	Metastatic	Prognostic	NULL		NULL	Clinically_validated	Somatic	Poor prognosis	22139329			MYC	Amplification	DLBCL	Metastatic	Prognostic	NULL		NULL	Clinically_validated	Somatic					MYC	Amplification	Burkitt's_lymphoma	Metastatic	Diagnostic	NULL		NULL	Clinically_validated	Somatic					MYC	Amplification	Neuroblastoma	Metastatic	Prognostic	NULL		NULL	Clinically_validated	Somatic					MYCN	Amplification	Neuroblastoma	Metastatic	Prognostic	NULL		NULL	NULL	Somatic	Poor prognisis	22139329			NF1	Inactivation	Ovarian	Metastatic	Prognostic	NULL		NULL	NULL	Somatic					NF2	Inactivation	Renal_cell_carcinoma	Metastatic	Diagnostic	NULL		NULL	NULL	Somatic	non-VHL mutated	20054297			NOTCH1	p.S953N	Head_and_neck	Metastatic	Resistance	MK-0752	NOTCH1 inhibitors | gamma secretase inhibitors	FALSE	Preclinical	Somatic		21798893			NOTCH1	p.D1517N	Head_and_neck	Metastatic	Resistance	MK-0752	NOTCH1 inhibitors | gamma secretase inhibitors	FALSE	Preclinical	Somatic		21798893			NOTCH1	p.F1411F	Head_and_neck	Metastatic	Resistance	MK-0752	NOTCH1 inhibitors | gamma secretase inhibitors	FALSE	Preclinical	Somatic		21798893			NOTCH1	p.Q1214*	Head_and_neck	Metastatic	Resistance	MK-0752	NOTCH1 inhibitors | gamma secretase inhibitors	FALSE	Preclinical	Somatic		21798893			NOTCH1	p.E719*	Head_and_neck	Metastatic	Resistance	MK-0752	NOTCH1 inhibitors | gamma secretase inhibitors	FALSE	Preclinical	Somatic		21798893			NOTCH1	p.G481S	Head_and_neck	Metastatic	Resistance	MK-0752	NOTCH1 inhibitors | gamma secretase inhibitors	FALSE	Preclinical	Somatic		21798893			NOTCH1	p.E424K	Head_and_neck	Metastatic	Resistance	MK-0752	NOTCH1 inhibitors | gamma secretase inhibitors	FALSE	Preclinical	Somatic		21798893			NOTCH1	p.P422S	Head_and_neck	Metastatic	Resistance	MK-0752	NOTCH1 inhibitors | gamma secretase inhibitors	FALSE	Preclinical	Somatic		21798893			NOTCH1	p.F357del	Head_and_neck	Metastatic	Resistance	MK-0752	NOTCH1 inhibitors | gamma secretase inhibitors	FALSE	Preclinical	Somatic		21798893			NPM1	p.W288fs*12	AML	Metastatic	Prognostic	NULL		NULL	Clinically_validated	Somatic					NRAS	p.G12A	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.G12D	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.G12V	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.G12C	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.G12S	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.G12R	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.G13A	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.G13D	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.G13V	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.G13R	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.Q61H	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.Q61L	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.Q61L	Lung	Metastatic	Resistance	erlotinib		TRUE	Limited	Somatic					NRAS	p.Q61P	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.Q61R	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.Q61R	Lung	Metastatic	Resistance	erlotinib		TRUE	Limited	Somatic					NRAS	p.Q61L	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.Q61E	Melanoma	Metastatic	Sensitivity	selumetinib	MAP2K1 inhibitor	FALSE	Limited	Somatic		18390968			NRAS	p.Q61K	Lung	Metastatic	Resistance	erlotinib		TRUE	Limited	Somatic					NRAS	p.Q61L	Lung	Metastatic	Resistance	gefitinib		TRUE	Limited	Somatic					NRAS	p.Q61R	Lung	Metastatic	Resistance	gefitinib		TRUE	Limited	Somatic					NRAS	p.Q61K	Lung	Metastatic	Resistance	gefitinib		TRUE	Limited	Somatic					PDGFRA	p.V561D	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.E571R	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.E571K	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.E571R	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.H845V	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.D842Y	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.D842I	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.D842V	GIST	Metastatic	Resistance	imatinib		TRUE	Limited	Somatic				"J Clin Oncol 28:15s, 2010 (suppl; abstr 10051)"	PDGFRA	p.D842Y	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.M844del	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.H845del	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.H845V	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.D846N	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.D846G	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.D846E	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.D846del	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.D846Y	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.S847>EA	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.S847T	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PDGFRA	p.N848P	GIST	Metastatic	Sensitivity	imatinib		TRUE	Limited	Somatic		14645423 | 16954519			PIK3CA	p.L633E	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.L633V	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.C420R	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.P539R	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.E542K	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.E542Q	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.E545K	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.E545Q	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.E545A	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.E545G	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.E545D	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.E545D	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.Q546K	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.H701P	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.Y1021C	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.M1043I	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.M1043I	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.H1047Y	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.H1047R	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.H1047L	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.G1049R	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.G1049S	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PIK3CA	p.N1068fs*4	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20453058			PTEN	p.R159S	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20085938			PTEN	p.R159S	Breast	Metastatic	Sensitivity	MK-2206	AKT inhibitor	FALSE	Limited	Somatic		20085938			PTEN	p.R159S	Breast	Metastatic	Sensitivity	CCI-779	Temserolimus	TRUE	Limited	Somatic		11504908			PTEN	p.R233*	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20085938			PTEN	p.R233*	Breast	Metastatic	Sensitivity	MK-2206	AKT inhibitor	FALSE	Limited	Somatic		20085938			PTEN	p.R233*	Breast	Metastatic	Sensitivity	CCI-779	Temserolimus	TRUE	Limited	Somatic		11504908			PTEN	p.R233*	Lung	Metastatic	Resistance	erlotinib	EGFR inhibitor	TRUE	Preclinical	Somatic		19351834			PTEN	p.R233*	Melanoma	Metastatic	Resistance	vemurafenib	BRAF inhibitor	TRUE	Preclinical	Somatic		21317224			PTEN	p.K267fs*9	Breast	Metastatic	Sensitivity	GDC-0941	PIK3CA inhibitor	FALSE	Limited	Somatic		20085938			PTEN	p.K267fs*9	Breast	Metastatic	Sensitivity	MK-2206	AKT inhibitor	FALSE	Limited	Somatic		20085938			PTEN	p.K267fs*9	Breast	Metastatic	Sensitivity	CCI-779	Temserolimus	TRUE	Limited	Somatic		11504908			PTEN	p.R233*	Lung	Metastatic	Resistance	gefitinib	EGFR inhibitor	TRUE	Preclinical	Somatic		19351834			RET	p.C620del	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.D631G	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.L633E	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.L633V	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.L633V	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.C634R	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.C634Y	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.C634W	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.A640>VRP	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.E768D	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.A883F	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.A883F	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.E901del	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			RET	p.M918T	Medullary_thyroid_cancer	Metastatic	Sensitivity	XL-184	RET inhibitor	FALSE	Limited	Somatic		21606412			SMO	mutation	Medulloblastoma	Metastatic	Sensitivity	GDC-0449	SMO antagonist	FALSE	Limited Evidence	Somatic					SMO	mutation	Basal cell carcinoma	Metastatic	Sensitivity	GDC-0449	SMO antagonist	FALSE	Limited Evidence	Somatic		19726763			SMO	mutation	Colorectal	Metastatic	Sensitivity	GDC-0449	SMO antagonist	FALSE	Limited Evidence	Somatic					SMO	mutation	Ovarian	Metastatic	Sensitivity	GDC-0449	SMO antagonist	FALSE	Limited Evidence	Somatic					TP53	biallelic inactivation	Cancer	Metastatic	Prognostic	NA									